PLX

#3115
Protalix BioTherapeutics, Inc. Common Stock
2.8300 USD
+1.07%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
2.7890
2.8450
년간 변동
2.5850
3.1900
일일 변동
+1.07%
월간 변동
-3.08%
6달 변화
-3.08%
년간 변동율
-3.08%
이전 종가
2.8000
Open
2.8200
Bid
2.8300
Ask
2.8330
Low
2.7890
High
2.8450
양
288
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

뉴스